245 related articles for article (PubMed ID: 35363115)
1. Selective delivery of curcumin to breast cancer cells by self-targeting apoferritin nanocages with pH-responsive and low toxicity.
Ji P; Wang X; Yin J; Mou Y; Huang H; Ren Z
Drug Deliv; 2022 Dec; 29(1):986-996. PubMed ID: 35363115
[TBL] [Abstract][Full Text] [Related]
2. Green synthesis of carrier-free curcumin nanodrugs for light-activated breast cancer photodynamic therapy.
Sun M; Zhang Y; He Y; Xiong M; Huang H; Pei S; Liao J; Wang Y; Shao D
Colloids Surf B Biointerfaces; 2019 Aug; 180():313-318. PubMed ID: 31071571
[TBL] [Abstract][Full Text] [Related]
3. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
[TBL] [Abstract][Full Text] [Related]
4. Efficient synergistic combination effect of Quercetin with Curcumin on breast cancer cell apoptosis through their loading into Apo ferritin cavity.
Mansourizadeh F; Alberti D; Bitonto V; Tripepi M; Sepehri H; Khoee S; Geninatti Crich S
Colloids Surf B Biointerfaces; 2020 Jul; 191():110982. PubMed ID: 32220813
[TBL] [Abstract][Full Text] [Related]
5. Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis.
Liu L; Sun L; Wu Q; Guo W; Li L; Chen Y; Li Y; Gong C; Qian Z; Wei Y
Int J Pharm; 2013 Feb; 443(1-2):175-82. PubMed ID: 23287774
[TBL] [Abstract][Full Text] [Related]
6. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid coating on the surface of curcumin-loaded ZIF-8 nanoparticles for improved breast cancer therapy: An in vitro and in vivo study.
Yu S; Wang S; Xie Z; Yu S; Li L; Xiao H; Song Y
Colloids Surf B Biointerfaces; 2021 Jul; 203():111759. PubMed ID: 33892283
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of paclitaxel and curcumin by biodegradable polymeric nanoparticles for breast cancer chemotherapy.
Xiong K; Zhang Y; Wen Q; Luo J; Lu Y; Wu Z; Wang B; Chen Y; Zhao L; Fu S
Int J Pharm; 2020 Nov; 589():119875. PubMed ID: 32919003
[TBL] [Abstract][Full Text] [Related]
9. κ-Carrageenan: An effective drug carrier to deliver curcumin in cancer cells and to induce apoptosis.
Sathuvan M; Thangam R; Gajendiran M; Vivek R; Balasubramanian S; Nagaraj S; Gunasekaran P; Madhan B; Rengasamy R
Carbohydr Polym; 2017 Mar; 160():184-193. PubMed ID: 28115093
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional redox-responsive and CD44 receptor targeting polymer-drug nanomedicine based curcumin and alendronate: synthesis, characterization and in vitro evaluation.
Dong X; Zou S; Guo C; Wang K; Zhao F; Fan H; Yin J; Chen D
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):168-177. PubMed ID: 29239219
[TBL] [Abstract][Full Text] [Related]
11. Novel multifunctional triple folic acid, biotin and CD44 targeting pH-sensitive nano-actiniaes for breast cancer combinational therapy.
Liu M; Wang B; Guo C; Hou X; Cheng Z; Chen D
Drug Deliv; 2019 Dec; 26(1):1002-1016. PubMed ID: 31571501
[TBL] [Abstract][Full Text] [Related]
12. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
[TBL] [Abstract][Full Text] [Related]
13. Combined Ferritin Nanocarriers with ICG for Effective Phototherapy Against Breast Cancer.
Sitia L; Saccomandi P; Bianchi L; Sevieri M; Sottani C; Allevi R; Grignani E; Mazzucchelli S; Corsi F
Int J Nanomedicine; 2024; 19():4263-4278. PubMed ID: 38766663
[TBL] [Abstract][Full Text] [Related]
14. Toxicity Reduction and Efficacy Promotion of Doxorubicin in the Treatment of Breast Tumors Assisted by Enhanced Oral Absorption of Curcumin-Loaded Lipid-Polyester Mixed Nanoparticles.
Wang N; Zhang Y; Liu H; Wang A; Ren T; Gou J; Zhang Y; Yin T; He H; Tang X
Mol Pharm; 2020 Dec; 17(12):4533-4547. PubMed ID: 33201717
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
[TBL] [Abstract][Full Text] [Related]
17. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
[TBL] [Abstract][Full Text] [Related]
18. Curcumin Delivery by Poly(Lactide)-Based Co-Polymeric Micelles: An In Vitro Anticancer Study.
Kumari P; Swami MO; Nadipalli SK; Myneni S; Ghosh B; Biswas S
Pharm Res; 2016 Apr; 33(4):826-41. PubMed ID: 26597940
[TBL] [Abstract][Full Text] [Related]
19. Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery.
Malekmohammadi S; Hadadzadeh H; Farrokhpour H; Amirghofran Z
Soft Matter; 2018 Mar; 14(12):2400-2410. PubMed ID: 29512668
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
Lin M; Teng L; Wang Y; Zhang J; Sun X
Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
